









Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
BIO 206 - Chapter 1 Lecture Material Type: Notes; Class: Genetics; Subject: Biology; University: University of Missouri-Kansas City; Term: Fall 2013;
Typology: Study notes
1 / 16
This page cannot be seen from the preview
Don't miss anything!
Life on Earth – Rich and Complex
Each cell of an organism has a complement of DNA Covered in Chapters 7, 8, and 9 1.1 The Nature of Biological Information
DNA is biological information
A diploid genome visualized diploid organism – two identical chromosome sets homologous chromosomes or homologs – a chromosome pair contained within a diploid, “nearly identical” DNA sequence haploid organism – one chromosome set
Representative chromosomal landscapes
The flow of information in a eukaryotic cell Covered in Chapters 7, 8, and 9
Evolutionary tree based on comparisons of cytochrome c DNA 1.3 Genetics and Evolution Covered in Chapters 18, 19, and 20
1.4 Genetics has Provided a Powerful Approach to Biological Research Forward genetics - search for a genetic difference that causes a “phenotypic” difference Mutation to gene discovery to DNA sequence and function Reverse genetics - search for a genetic difference that causes a “phenotypic” difference Gene (DNA sequence) to mutation to function
Some organisms used as models in genetic research 1.5 Model Organisms Have been Crucial in the Genetics Revolution
Nikhil et al., Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling. 2011. J. Clin. Oncol. 29: 3085-3096. A 38 yr old man with BRAF- mutant melanoma and subcutaneous metastatic deposits. (A) before treatment with PLX4032, (B) after 15 weeks of therapy with PLX4032, and (C) relapse after 23 weeks of PLX4032 = targeted cancer therapy drug. therapy